Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14050980
Abstract: Contraceptives such as Depo-medroxyprogesterone (DMPA) are used by an estimated 34 million women worldwide. DMPA has been associated with increased risk of several viral infections including Herpes simplex virus-2 (HSV-2) and Human immunodeficiency virus (HIV).… read more here.
Keywords: anogenital tract; tract; depo medroxyprogesterone; model ... See more keywords